Insmed iPlex Growth Agent “Approvable” Letter Leaves Orphan Status Issue Open
This article was originally published in The Pink Sheet Daily
Executive Summary
Exclusivity discussions with Office of Orphan Products Development are ongoing, CEO Geoffrey Allan says Sept. 28; letter requests chemistry, manufacturing and controls data.